Recro Pharma

Malvern,  PA 
United States
  • Booth: 1336


Recro Pharma is a revenue-generating, specialty pharmaceutical company focused on products for hospitals/ambulatory care settings. We are currently developing non-opioids for the treatment of acute pain, including our lead investigational compound, IV meloxicam, a proprietary, long-acting preferential COX-2 inhibitor for moderate to severe post-operative pain. On July 31, 2017, we announced the submission of a New Drug Application (NDA) for IV meloxicam to the FDA.


  • Pharmaceuticals